semaglutide news november 2025 What the Obesity Drugmakers Expect in November 2025 Drug Safety: Recalls
Description
Glucagon-like peptide1 receptor agonists (GLP-1RAs) have emerged as a transformative class of therapies initially developed for glycemic control in type2 diabetes mellitus
Learn why the 4-week titration is vital for safety and how to manage early side effects.
Here's the latest news on that story.
Welcome to Hospitalogy, a newsletter breaking down healthcare finance, M&A, and strategy twice weekly
Various pharmaceutical and research-focused manufacturers now package peptide formulations under different product systems, including multi-dose pen devices
Learn if Aetna covers Phentermine and how to secure coverage
